Oda Keiko, Usui Joichi, Kanetsuna Yukiko, Murata Tomohiro, Ozeki Takaya, Shimizu Akira, Sugiyama Hitoshi, Maruyama Shoichi
Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.
Department of Nephrology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
Clin Exp Nephrol. 2025 May 8. doi: 10.1007/s10157-025-02685-w.
Tubulointerstitial nephritis (TIN) is an important disease involving a diverse set of factors that can cause both acute kidney injury and chronic kidney disease. The purpose of this cross-sectional study was to clarify the causative diseases and clinicopathological characteristics of TIN using the Japan Renal Biopsy Registry (J-RBR).
This cross-sectional study analyzed data from 22,049 cases registered in the J-RBR between 2018 and 2022. Clinicopathological findings at diagnosis were investigated.
Of the enrolled cases, 913 were diagnosed with TIN. "Drug-induced" was the most common (232 cases, 25.7%), followed by "IgG4-related kidney disease" (124 cases, 13.7%). Of "Drug-induced" TIN cases, "Chemotherapy-related" was the most common cause (63 cases, 27.2%), including 47 cases of "immune checkpoint inhibitor (ICI)-associated" TIN. IgM-positive plasma cell-rich TIN (IgMPC-TIN), which has been the focus of much attention in recent years, was also included, with 9 cases.
This is the first report of the clinicopathological findings of TIN patients in a large-scale, nationwide registry of renal biopsies. It was possible to identify recent trends in causative diseases, including an increase in chemotherapy-related TIN and IgMPC-TIN.
肾小管间质性肾炎(TIN)是一种重要疾病,涉及多种可导致急性肾损伤和慢性肾脏病的因素。本横断面研究旨在利用日本肾活检登记系统(J-RBR)阐明TIN的致病疾病及临床病理特征。
本横断面研究分析了2018年至2022年期间登记在J-RBR中的22049例病例的数据。对诊断时的临床病理结果进行了调查。
在纳入的病例中,913例被诊断为TIN。“药物性”最为常见(232例,25.7%),其次是“IgG4相关性肾病”(124例,13.7%)。在“药物性”TIN病例中,“化疗相关”是最常见的原因(63例,27.2%),其中包括47例“免疫检查点抑制剂(ICI)相关性”TIN。近年来备受关注的IgM阳性富含浆细胞的TIN(IgMPC-TIN)也有9例。
这是在大规模全国性肾活检登记系统中关于TIN患者临床病理结果的首份报告。能够确定致病疾病的近期趋势,包括化疗相关TIN和IgMPC-TIN的增加。